These findings indicated that GPR120, currently a target for the treatment of type 2 diabetes26, 27, 28, and the newly found “obesity gene” that forecasts obesity, could have bonus effects on the prevention of osteoporosis and obesity in the future. The gene discussed is FFAR4; the disease is obesity due to melanocortin 4 receptor deficiency.